Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BGNE

BeiGene (BGNE)

BeiGene Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BGNE
DateTimeSourceHeadlineSymbolCompany
08/02/20235:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
08/02/20236:23AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BGNEBeiGene Ltd
08/02/20236:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
08/02/20236:00AMBusiness WireBeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial ResultsNASDAQ:BGNEBeiGene Ltd
07/31/20234:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BGNEBeiGene Ltd
07/24/20234:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
07/21/20238:33AMDow Jones NewsBeiGene Gets Positive CHMP Opinion for Tislelizumab to Treat Serious Esophageal CancerNASDAQ:BGNEBeiGene Ltd
07/21/20237:50AMBusiness WireBeiGene Announces Positive CHMP Opinion for Tislelizumab as a Treatment for Advanced or Metastatic ESCCNASDAQ:BGNEBeiGene Ltd
07/12/20237:48AMDow Jones NewsBeiGene: FDA to Review Brukinsa Combo in Relapsed, Refractory Follicular LymphomaNASDAQ:BGNEBeiGene Ltd
07/12/20237:00AMBusiness WireBeiGene Announces FDA Acceptance of sNDA for Fifth BRUKINSA® IndicationNASDAQ:BGNEBeiGene Ltd
07/11/20236:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
07/10/20237:00AMBusiness WireBeiGene and DualityBio Announce Partnership to Advance Differentiated Antibody Drug Conjugate (ADC) Therapy for Solid TumorsNASDAQ:BGNEBeiGene Ltd
07/07/20237:00AMBusiness WireBeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023NASDAQ:BGNEBeiGene Ltd
07/06/20235:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/27/20235:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/26/20236:11PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:BGNEBeiGene Ltd
06/26/20236:07PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:BGNEBeiGene Ltd
06/23/20234:13PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:BGNEBeiGene Ltd
06/21/20236:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/21/20236:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/21/20236:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/21/20236:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/21/20236:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/21/20236:00AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BGNEBeiGene Ltd
06/20/20237:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/20/20237:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/20/20236:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/20/20236:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/20/20236:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
06/20/20234:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BGNEBeiGene Ltd
 Showing the most relevant articles for your search:NASDAQ:BGNE